Beckman Coulter Life Sciences and IncellDx Announce Collaboration
Beckman Coulter Life Sciences and IncellDx have announced a collaboration aimed at creating awareness for the oncology assays on the cytometry platform for European customers.
Beckman Coulter Life Sciences and IncellDx have announced, in a Nov. 20, 2019 press release, a collaboration aimed at creating awareness for the oncology assays on the cytometry platform for European customers.
Four cancer detection reagents were developed by IncellDx using Beckman Coulter’s instruments, under the partnership. The assays relate to lung and bladder cancers as well as human papillomavirus (HPV) cancers affecting the head, neck, and cervix.
“The new partnership brings the power of multi-parameter flow cytometry to molecular testing, improving workflow while delivering sensitive and highly reliable cell identification,” said Mario Koksch, vice-president and general manager, Beckman Coulter Life Sciences Cytometry Business Unit, in the press release. “In addition, the oncology menu of IncellDx adds a new dimension to Beckman Coulter instruments, such as the CytoFLEX Series, which positions our technology at the forefront of clinical research.”
Bruce Patterson, CEO and founder of IncellDx, commented, “In cancer research, it is essential to carry out quantification at the single cell level. Adding our single cell, simultaneous protein, mRNA, and cell cycle/DNA content assays to the technology behind Beckman Coulter Life Sciences flow cytometry instruments will open up a new era in understanding cancer biology.”
Source: Beckman Coulter
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
